Patents by Inventor Carsten BRUESEWITZ

Carsten BRUESEWITZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250134900
    Abstract: The present invention relates to a pharmaceutical composition comprising poorly soluble compounds such as BSC class II or IV kinase inhibitors, a process for the preparation thereof and its use in the treatment of diseases, in particular cancer, further particularly in non-small lung cancer.
    Type: Application
    Filed: January 4, 2025
    Publication date: May 1, 2025
    Applicants: Hoffmann-La Roche Inc., Chugai Seiyaku Kabushiki Kaisha
    Inventors: Susanne MEIER, Carsten BRUESEWITZ
  • Publication number: 20240299403
    Abstract: The present invention relates to a pharmaceutical composition comprising poorly soluble compounds such as BSC class II or IV kinase inhibitors, a process for the preparation thereof and its use in the treatment of diseases, in particular cancer. further particularly in non-small lung cancer.
    Type: Application
    Filed: May 9, 2024
    Publication date: September 12, 2024
    Applicants: Hoffmann-La Roche Inc., Chugai Seiyaku Kabushiki Kaisha
    Inventors: Susanne MEIER, Carsten BRUESEWITZ
  • Patent number: 12005064
    Abstract: The present invention relates to a pharmaceutical composition comprising poorly soluble compounds such as BSC class II or IV kinase inhibitors, a process for the preparation thereof and its use in the treatment of diseases, in particular cancer, further particularly in non-small lung cancer.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: June 11, 2024
    Assignees: Hoffmann-La Roche Inc., Chugai Seiyaku Kabushiki Kaisha
    Inventors: Susanne Meier, Carsten Bruesewitz
  • Publication number: 20200397794
    Abstract: The present invention relates to a pharmaceutical composition comprising poorly soluble compounds such as BSC class II or IV kinase inhibitors, a process for the preparation thereof and its use in the treatment of diseases, in particular cancer, further particularly in non-small lung cancer.
    Type: Application
    Filed: January 27, 2020
    Publication date: December 24, 2020
    Applicants: Hoffmann-La Roche Inc., Chugai Seiyaku Kabushiki Kaisha
    Inventors: Susanne Meier, Carsten Bruesewitz
  • Publication number: 20170119781
    Abstract: The present invention relates to a pharmaceutical composition comprising poorly soluble compounds such as BSC class II or IV kinase inhibitors, a process for the preparation thereof and its use in the treatment of diseases, in particular cancer, further particularly in non-small lung cancer.
    Type: Application
    Filed: December 19, 2016
    Publication date: May 4, 2017
    Applicants: Hoffmann-La Roche Inc., CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Susanne MEIER, Carsten BRUESEWITZ